New Delhi, India

Seema Khan

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2017.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seema Khan: Innovator in Anti-Dengue Pharmaceutical Compositions

Introduction

Seema Khan is a notable inventor based in New Delhi, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-dengue treatments. Her innovative work has led to the creation of a patent that addresses the pressing health issue of dengue fever.

Latest Patents

Seema Khan holds 1 patent related to the anti-dengue activity of specific extracts. The patent encompasses pharmaceutical compositions that include these extracts and outlines the processes for their preparation. This invention is crucial in the fight against dengue, providing new avenues for treatment.

Career Highlights

Throughout her career, Seema Khan has worked with prominent companies in the pharmaceutical industry. She has been associated with Sun Pharmaceutical Industries Limited and Ranbaxy Laboratories, Inc. Her experience in these organizations has contributed to her expertise and innovative capabilities in drug development.

Collaborations

Seema has collaborated with notable professionals in her field, including Pawan Kumar Pareek and Navin Khanna. These collaborations have further enhanced her research and development efforts, leading to impactful advancements in pharmaceutical compositions.

Conclusion

Seema Khan's contributions to the pharmaceutical industry, particularly in anti-dengue innovations, highlight her role as a significant inventor. Her work not only addresses critical health challenges but also showcases the importance of innovation in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…